Table 3.
Systemic primary thromboprophylaxis in pediatrics.
| Indicationa | Level of evidence |
|---|---|
| Long-term total parenteral nutrition | 2C |
| Hemodialysis | 2C |
| Moderate or giant coronary aneurysms in Kawasaki disease | 2C |
| Cardiopathy | |
| Fontan surgery | 1B |
| Cardiac catheterization via an artery | 1A |
| Bilateral cavopulmonary shunt/Blalock-Taussig shunt | 2C |
| Ventricular assist devices | 2C |
| Dilated cardiomyopathy | 2C |
| Primary Pulmonary Hypertension | 2C |
| Endovascular Stents | 2C |
| Prosthetic heart valvesb | |
a
Recommendations from the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 9th edition, 2012.
b
Recommendations from the adult population guidelines.